HyperRAB S/D and Inotersen Subcutaneous
Determining the interaction of HyperRAB S/D and Inotersen Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: rabies immune globulin, human
Brand name: Bayrab, HyperRAB, Imogam Rabies-HT, Kedrab
Synonyms: HyperRAB (human)
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- HyperRAB S/D-Inotuzumab ozogamicin
- HyperRAB S/D-Inotuzumab ozogamicin Intravenous
- HyperRAB S/D-Inova
- HyperRAB S/D-Inova 4/1 topical
- HyperRAB S/D-Inova 8/2 topical
- HyperRAB S/D-Inova ACT
- Inotersen Subcutaneous-HyperRHO S/D
- Inotersen Subcutaneous-HyperRHO S/D Full Dose
- Inotersen Subcutaneous-HyperRHO S/D Mini Dose
- Inotersen Subcutaneous-HyperSal
- Inotersen Subcutaneous-Hyperstat
- Inotersen Subcutaneous-HyperTET S/D